Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021–2022 I‐MOVE primary care multicentre studyEsther Kissling, Neus Latorre‐Margalef, Sanja Filipović et al.|Influenza and Other Respiratory Viruses|2022Cited by 45
Influenza vaccine effectiveness in Europe: Results from the 2022–2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre studyMarine Maurel, Francisco Pozo, Gloria Pérez‐Gimeno et al.|Influenza and Other Respiratory Viruses|2024Cited by 28
Influenza vaccine effectiveness against influenza A subtypes in Europe: results from the 2021–22 I-MOVE primary care multicentre studyEsther Kissling, Marta Valenciano, Francisco Pozo et al.|Unknown|2022Cited by 1
Influenza vaccine effectiveness in Europe: Results from the 2022–23 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre studyMarine Maurel, VEBIS study team, Francisco Pozo et al.|Unknown|2023Cited by 0
Author response for "Influenza vaccine effectiveness in Europe: Results from the 2022–2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study"Marine Maurel, VEBIS study team, Francisco Pozo et al.|Unknown|2023Cited by 0